Amidst the fury of the pandemic, Krishna Ella was a man consumed by work. He had quite a task at hand — to develop India’s first indigenous Covid-19 vaccine, Covaxin. Our meeting, long anticipated but delayed due to his intense involvement, finally materialises now that the shadow of Covid-19 is receding.
The executive chairperson of Bharat Biotech graciously hosts me in his hometown, Hyderabad, choosing the serene ambiance of Yi Jing at ITC Kohenur, an establishment nestled in the heart of the bustling Hitec City, overlooking the tranquil Durgam Lake.
Yi Jing’s vibrant red decor provides the backdrop as we